Drug or treatment

Repotrectinib clinical trials

• 6Clinical trials
• 20Countries

Newest trials

All recruiting trials (6)

• Repotrectinib safety in children with NTRK fusion cancers in Japan

  This study tests the safety of repotrectinib in children and teens with NTRK fusion–positive solid tumors in Japan during routine care.

  Recruiting at 2 sites Bristol-Myers Squibb · Minato-ku, Tokyo and 1 other locations · NCT07755826

• Testing Repotrectinib in Elderly and Frail Patients with Advanced NSCLC

  This study is testing a new cancer drug called repotrectinib to see if it helps older and frail patients with advanced lung cancer feel better and tolerate the treatment well.

  Recruiting at 20 sites Phase 2 Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · Aix-en-Provence, Bouches Du Rhône and 19 other locations · NCT06552234

• Repotrectinib for treating ROS1-positive lung cancer with brain metastasis

  This study is testing a new drug called repotrectinib to see if it can help people with ROS1-positive lung cancer that has spread to the brain.

  Recruiting at 17 sites Phase 2 MedSIR · Graz and 16 other locations · NCT06315010

• Testing repotrectinib with chemotherapy for children and young adults with advanced solid tumors

  This study is testing if the drug repotrectinib, when combined with chemotherapy, can help children and young adults with advanced solid tumors feel better and improve their treatment outcomes.

  Recruiting Phase 1/2 Memorial Sloan Kettering Cancer Center · New York, New York · NCT05004116

• Treatment with repotrectinib for young patients with specific genetic alterations in tumors

  This study is testing a new oral medication called repotrectinib to see if it can help young patients with advanced tumors that have certain genetic changes when other treatments haven't worked.

  Recruiting at 44 sites Phase 1/2 Turning Point Therapeutics, Inc. · Los Angeles, California and 67 other locations · NCT04094610

• Testing repotrectinib in patients with advanced solid tumors with specific gene rearrangements

  This study is testing a new drug called repotrectinib to see if it can help people with advanced solid tumors that have certain gene changes.

  Recruiting at 63 sites Phase 1/2 Turning Point Therapeutics, Inc. · Duarte, California and 164 other locations · NCT03093116

Quick answers

How many clinical trials of Repotrectinib are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 20 countries. The most sites are in France (3 trials), Spain (3 trials), United States (3 trials), Australia (2 trials), Canada (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 3, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →